We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Implantable Shock Absorber Can Prevent or Delay Knee Replacement in Osteoarthritis Patients

By HospiMedica International staff writers
Posted on 23 Sep 2022

Of the 14 million Americans suffering with the pain of knee osteoarthritis, more than half are under 65, making a knee replacement undesirable, as the prosthetic would likely need to be replaced in their lifetime. More...

Few options exist to get patients back on their feet or to slow joint degradation without major surgery that permanently alters the anatomy of the knee. Now, the results of a clinical trial show that an implantable device can not only make daily activities more comfortable, but delay the need for a knee replacement.

The new implantable device that works as a shock absorber was developed by researchers at The Ohio State University Wexner Medical Center (Columbus, OH, USA) and may soon give those with progressing knee osteoarthritis a new option to reduce pain, improve functionality and delay the need for a total knee replacement. As part of a clinical trial, the researchers implanted the new device designed to take strain off the knee of patients with osteoarthritis. Nearly three years later, the trial results are positive for nearly all of the participants. The device improved pain and functionality for more than 90% of the patients who received it. The results of the clinical trial with two years of patient follow-ups were recently presented, and the data has been submitted to the FDA.

“It is a shock absorber that is anchored to the bone, and when you’re walking or doing other activities it takes away about 30% of the stress on that knee every time you put weight on it,” said Dr. David Flanigan, professor of orthopedics and director of the Cartilage Restoration Program at The Ohio State University Wexner Medical Center. “Over 90% of the trial patients have been able to get back to the activities that have been causing them pain for quite some time and experienced significant improvements in pain and function.”

Related Links:
The Ohio State University


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.